BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27878892)

  • 1. Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.
    Ishii T; Angata T; Wan ES; Cho MH; Motegi T; Gao C; Ohtsubo K; Kitazume S; Gemma A; ParÉ PD; Lomas DA; Silverman EK; Taniguchi N; Kida K
    Respirology; 2017 May; 22(4):684-690. PubMed ID: 27878892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of group component genetic variations in COPD and COPD exacerbation in a Japanese population.
    Ishii T; Motegi T; Kamio K; Gemma A; Kida K
    Respirology; 2014 May; 19(4):590-5. PubMed ID: 24735339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of Siglec-9 in chronic obstructive pulmonary disease.
    Zeng Z; Li M; Wang M; Wu X; Li Q; Ning Q; Zhao J; Xu Y; Xie J
    Sci Rep; 2017 Aug; 7(1):10116. PubMed ID: 28860481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese.
    Ito M; Hanaoka M; Droma Y; Hatayama O; Sato E; Katsuyama Y; Fujimoto K; Ota M
    Intern Med; 2008; 47(15):1387-94. PubMed ID: 18670143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.
    Ge L; Wang N; Chen Z; Xu S; Zhou L
    Cytokine; 2024 May; 177():156558. PubMed ID: 38412768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.
    Angata T; Ishii T; Motegi T; Oka R; Taylor RE; Soto PC; Chang YC; Secundino I; Gao CX; Ohtsubo K; Kitazume S; Nizet V; Varki A; Gemma A; Kida K; Taniguchi N
    Cell Mol Life Sci; 2013 Sep; 70(17):3199-210. PubMed ID: 23519826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
    Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
    Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive pulmonary disease.
    Saito T; Fujino N; Kyogoku Y; Yamada M; Okutomo K; Ono Y; Konno S; Endo T; Itakura K; Matsumoto S; Sano H; Aizawa H; Numakura T; Onodera K; Okada Y; Hussell T; Ichinose M; Sugiura H
    Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L672-L686. PubMed ID: 38530936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ET-1 gene polymorphisms with COPD phenotypes in a Caucasian population.
    Kaparianos A; Sampsonas F; Lykouras D; Efremidis G; Drakatos P; Karkoulias K; Gogos C; Spiropoulos K
    Monaldi Arch Chest Dis; 2011 Jun; 75(2):126-31. PubMed ID: 21932697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.
    Küçükaycan M; Van Krugten M; Pennings HJ; Huizinga TW; Buurman WA; Dentener MA; Wouters EF
    Respir Res; 2002; 3(1):29. PubMed ID: 12537602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.
    Sun W; Kechris K; Jacobson S; Drummond MB; Hawkins GA; Yang J; Chen TH; Quibrera PM; Anderson W; Barr RG; Basta PV; Bleecker ER; Beaty T; Casaburi R; Castaldi P; Cho MH; Comellas A; Crapo JD; Criner G; Demeo D; Christenson SA; Couper DJ; Curtis JL; Doerschuk CM; Freeman CM; Gouskova NA; Han MK; Hanania NA; Hansel NN; Hersh CP; Hoffman EA; Kaner RJ; Kanner RE; Kleerup EC; Lutz S; Martinez FJ; Meyers DA; Peters SP; Regan EA; Rennard SI; Scholand MB; Silverman EK; Woodruff PG; O'Neal WK; Bowler RP; ;
    PLoS Genet; 2016 Aug; 12(8):e1006011. PubMed ID: 27532455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.
    Kim WJ; Oh YM; Kim TH; Lee JH; Kim EK; Lee JH; Lee SM; Shin TR; Yoon HI; Lim SY; Lee SD
    Respiration; 2013; 86(2):117-22. PubMed ID: 23207642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NOD2 gene polymorphism is associated with the prevalence and severity of chronic obstructive pulmonary disease in a Japanese population.
    Kinose D; Ogawa E; Hirota T; Ito I; Kudo M; Haruna A; Marumo S; Hoshino Y; Muro S; Hirai T; Sakai H; Date H; Tamari M; Mishima M
    Respirology; 2012 Jan; 17(1):164-71. PubMed ID: 21943069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of
    Ozretić P; da Silva Filho MI; Catalano C; Sokolović I; Vukić-Dugac A; Šutić M; Kurtović M; Bubanović G; Popović-Grle S; Skrinjarić-Cincar S; Vugrek O; Jukić I; Rumora L; Bosnar M; Samaržija M; Bals R; Jakopović M; Försti A; Knežević J
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31601004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.
    Yu ZG; Wang BZ; Cheng ZZ
    Kaohsiung J Med Sci; 2017 Sep; 33(9):433-441. PubMed ID: 28865600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic variation in surfactant protein B is associated with COPD exacerbations.
    Foreman MG; DeMeo DL; Hersh CP; Carey VJ; Fan VS; Reilly JJ; Shapiro SD; Silverman EK
    Eur Respir J; 2008 Oct; 32(4):938-44. PubMed ID: 18550614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity.
    Sata M; Takabatake N; Inoue S; Shibata Y; Abe S; Machiya J; Wada T; Ji G; Kido T; Matsuura T; Muramatsu MA; Kubota I
    Respirology; 2007 Jan; 12(1):34-41. PubMed ID: 17207023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.
    Liu Y; Liang WB; Gao LB; Pan XM; Chen TY; Wang YY; Xue H; Zhang LS; Zhang L
    Hum Immunol; 2010 Nov; 71(11):1141-6. PubMed ID: 20732370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.
    Sørheim IC; DeMeo DL; Washko G; Litonjua A; Sparrow D; Bowler R; Bakke P; Pillai SG; Coxson HO; Lomas DA; Silverman EK; Hersh CP;
    COPD; 2010 Aug; 7(4):262-8. PubMed ID: 20673035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.